Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
406.4 DKK | -0.26% | -3.10% | +9.65% |
05-10 | NOVONESIS : Key segments outperform in average Q1 24 showing | |
05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.65% | 27.14B | |
+11.09% | 1.79B | |
-7.28% | 661M | |
-26.05% | 396M | |
-81.65% | 216M | |
-13.42% | 111M | |
-25.00% | 50.19M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes A/S Announces Executive Appointments, Effective April 2021